Articles tagged with Clinical Trials
Clinical Research Management has secured a seven-year contract to conduct Phase I Clinical Trials for Therapeutics against Infectious Diseases at three national testing sites. The sites are Case Western Reserve University School of Medicine and University Hospitals Case Medical Center, and Johns Hopkins University. Each site will recei...
The study found that patients treated with IGIV demonstrated significantly better cognitive function, daily functioning, and activities of daily living compared to those receiving placebo. The benefits persisted over 9 months, showing promise for IGIV as an antiamyloid immunotherapy for Alzheimer's disease.
Bapineuzumab showed potential efficacy signals in treating Alzheimer's disease without a clear dose response. Post-hoc analyses revealed statistically significant benefits in subgroups, including ApoE4 non-carrier patients.
The Hospital Clínic de Barcelona is part of the ICREL project, which aims to analyze the impact of European legislation on clinical trials. The project involves multiple stakeholders and will gather information from surveys to adapt current legislation and identify areas for improvement.
A study by the American Society of Plastic Surgeons found that lower belly fat contains higher concentrations of adult stem cells than other body areas. This discovery holds promise for future treatments using stem cells to repair or replace damaged tissue, including conditions like breast cancer and Parkinson's disease.
Gene therapy research in low- and middle-income countries has raised concerns about the ethical use of patients from deprived populations. Researchers argue that these trials should address local health needs and be affordable for implementation in those countries' healthcare systems.
The Orange County Resuscitation Outcomes Consortium is conducting a clinical trial to test the effectiveness of hypertonic saline solution in treating victims of severe traumatic injury. The study, which includes UC Irvine and other local hospitals, aims to improve survival rates from cardiac arrest and severe trauma.
Monash University scientists have initiated a clinical trials program for a footrot vaccine using reverse vaccinology to identify potential antigens. The goal is to develop a cross-protective vaccine that could significantly reduce the financial impact of footrot on the Australian wool and livestock industry.
A meta-analysis of randomized trials suggests that an invasive treatment strategy is associated with reduced risk of rehospitalization, heart attack, or death in men and high-risk women with certain coronary syndromes. However, low-risk women may have an increased risk of heart attack or death with this treatment.
Researchers Francesco Checchi and Les Roberts argue that an independent body is needed to accurately document death rates during humanitarian emergencies. Such a body could provide a basis for both humanitarian advocacy and political advocacy, and could help prevent the DRC experience from being repeated.
A small study of 18 patients with severe Marfan syndrome found that losartan slowed aortic enlargement by nearly half, offering a promising new treatment option. The study's findings have led to the approval of a large-scale clinical trial for losartan in Marfan syndrome patients.
Participants in a clinical trial reported multiple motivations for continued participation, with 80% citing personal benefit and helping others as key reasons. They also expressed pride in advancing scientific knowledge and believed their contribution was important to society.
RA patients prioritise pain, function, and fatigue when evaluating disease impact; trust in physicians, potential benefits, and payment are key motivators for clinical trial enrolment.
A recent study published in the Journal of the American Dental Association found that pregnant women can receive safe dental treatment between 13-21 weeks gestation. The research showed no significant increase in adverse outcomes from periodontal treatment and essential dental care during this time frame.
A recent study found that teenagers and young adults aged 15-24 had an average accrual rate of just 16.6% in clinical trials between 2005 and 2008, compared to 44.1% for 5-14 year-olds. The low recruitment rates are attributed to inappropriate trial design, poor accessibility, and a lack of specialist cancer teams for this age group.
In a phase II clinical trial, 70% of patients with follicular lymphoma responded to treatment with galiximab and rituximab. The combination regimen achieved complete responses in 44% and partial responses in 26%. Further study is warranted to assess the efficacy and time-to-progression endpoint.
A study of ongoing randomized clinical trials in diabetes reveals that only 20% have primary outcomes important to patients, such as illness, pain, or death. The researchers emphasize the need for a standard set of patient-important outcomes in diabetes trials to improve their informativeness.
In a Phase II clinical trial, eribulin mesylate demonstrated significant anti-tumor activity in heavily pretreated patients with locally advanced or metastatic breast cancer. The study showed an Overall Response Rate of 9.3% and a manageable tolerability profile with low incidence of Grade 3 and 4 neuropathy.
A lifestyle intervention trial will determine optimal ways to translate research-developed programs to real-life settings in Chennai, India. The study aims to promote health behaviors, improved diet, weight loss, and increased physical activity to prevent diabetes in those at risk.
Researchers at the Burnham Institute have demonstrated successful enzyme replacement therapy to prevent hypophosphatasia in mice, paving the way for future clinical trials. The treatment maintains healthy bone mineral density and preserves skeletal structures, offering new hope for patients with this genetic disorder.
A randomized phase II study found a trend towards increased survival in patients with advanced pancreatic cancer treated with axitinib plus gemcitabine compared to gemcitabine alone. The median overall survival was longer in the axitinib group, but the finding requires further investigation in a phase III trial.
The new GSID HIV Data Browser provides a wealth of data collected during clinical trials of an AIDS vaccine, offering researchers a unique opportunity to study how the virus evolves and causes new infections. The browser links to preserved specimens and clinical information, allowing investigators to study the evolution of the virus an...
Researchers assessed various regimens for treating advanced gastric cancer and found that new agent-containing regimens can achieve higher response rates. Chemotherapy with 5-fluorouracil remains a mainstream treatment option, prolonging median survival time for AGC patients.
Researchers confirm long-term use of selective serotonin reuptake inhibitors as effective treatment for depression. A 6-9 month course is recommended after recovery from an episode, especially in those without major comorbidities.
A recent review of 49 clinical trials found that dairy products and calcium intake have no effect on weight loss. Only five trials showed weight loss, but this was often associated with other factors such as exercise or lifestyle changes.
The READ-2 study, a collaboration between JDRF, Johns Hopkins, and Genentech, found that ranibizumab injections significantly improved visual acuity and reduced excess retinal thickness in patients with diabetic macular edema. The treatment resulted in a 56% reduction in retinal thickness compared to laser photocoagulation therapy.
A JAMA study found that hemoglobin-based blood substitutes are associated with a 30% increased risk of death and a 2.7 times increased risk of heart attack in patients. The researchers argue for stricter regulations on the development of these products to prevent future safety concerns.
A systematic review published in PLoS Medicine identified a need for standardized measurements in pediatric clinical trials due to the lack of parent and child involvement in selecting outcomes. The study found that only three groups asked parents about the outcomes, while none involved children directly.
A 5-year study found that one or two rounds of mass treatment with azithromycin can eliminate trachoma infection in communities with moderate levels of infection. The trial showed a significant reduction in trachoma prevalence from 9.5% to 0.1% after just two years.
A breath monitoring device helps prevent the emergence of drug-resistant strains of HIV by tracking medication adherence in high-risk individuals. The device records patients' breath tests and provides real-time feedback to doctors.
The 'GeparQuattro' trial shows that combining anthracycline and taxane chemotherapy with trastuzumab improves HER2 breast cancer response rates to 41.3%, compared to 19.5% without trastuzumab. The regimen also minimizes cardiac toxicity, making it a promising treatment option.
A study found that aromatase inhibitors (AIs) do not increase the risk of heart problems in women who take them, contrary to previous fears. The research suggests AIs are superior to tamoxifen in reducing breast cancer recurrence and do not significantly worsen cardiovascular health.
A study suggests that the sponsor of rofecoxib, Merck, misrepresented the drug's safety profile in clinical trials involving patients with cognitive impairment. The analysis found a significant increase in mortality among rofecoxib patients compared to placebo patients, which was not reported by the sponsor.
The Michael J. Fox Foundation has awarded $5.6 million for a Phase 2 clinical trial investigating the potential of inosine to slow or stop Parkinson's disease progression. The study will determine the safety of using inosine to raise urate levels and assess optimal dosage for therapeutic effect.
The article addresses the importance of sharing data in clinical trials for heart studies, including situations where interim data should be shared with operational study personnel and sponsors. The authors emphasize the need for caution and careful consideration before releasing interim data, particularly when it comes to trial credib...
A randomized pilot trial found that lowering blood pressure to below 140 mm Hg reduced haematoma growth in patients with spontaneous intracerebral haemorrhage. The treatment also showed no significant adverse effects on clinical outcomes.
A literature review found no clear evidence of benefit or harm from increased water intake in healthy individuals. However, studies suggest that people with certain diseases and athletes may benefit from increased fluid intake. No single study indicates a need to drink the recommended '8x8' amount of water daily.
A study published in the Journal of General Internal Medicine found that disclosing a researcher's financial interests does not deter clinical trial participants, unless it involves ownership of equity. Patients rated financial disclosures as less important than risks and benefits when making their decisions.
Research shows that individuals who are anxious about appearing prejudiced may avoid interactions with people of different races due to fear of social disapproval. A study by Jennifer Richeson and Sophie Trawalter found that white participants focused on neutral black faces for longer periods than white faces, suggesting a cognitive bi...
A large randomized study found that angioplasty and stenting offer no benefit over medical therapy for patients with renal artery stenosis. After one year of follow-up, there were no differences in kidney function, blood pressure control, or major cardiovascular illness rates.
Recruitment of pediatric cancer patients into clinical trials is challenging due to age-specific barriers. The article emphasizes the need for more research and international cooperation to improve trial participation, particularly among young people.
A study examined 75 group-randomized oncology trials and found a substantial number of problems with the trials. Many relied on analyses that ignored group randomization altogether, raising concerns about type I errors. In contrast, HPV-based screening was found to be more accurate in detecting cervical precancerous lesions than cytology.
A review of 75 group-randomized cancer trials found that fewer than half used appropriate statistical methods to analyze results. The studies' flawed designs may have led to incorrect conclusions about intervention effectiveness.
A recent study analyzed data from over 216,000 patients in completed phase 3 randomized clinical trials. The results showed that new cancer treatments were found to be slightly superior to standard treatments in terms of patient outcomes such as survival.
A study found that hospitals participating in clinical trials have better quality of care, lower mortality rates, and improved processes for treating acute coronary syndrome. Patients treated at these hospitals had significantly better outcomes compared to those treated at non-participating hospitals.
Researchers found that tumour relapse rates were similar between lower dose regimens (50Gy, 41.6Gy, 39Gy) and the standard schedule. Both photographic and patient self-assessments suggested lower late adverse effects after these lower dose regimens.
Developing nations offer a ready supply of patients, large potential markets, and reduced competition for clinical trial sites. Companies conduct trials primarily in cities due to the presence of doctors, staff, and equipment similar to those found in Western conditions.
A study published in the American Journal of Preventive Medicine found that after-school programs increased moderate-to-vigorous physical activity among middle school girls by 80 calories a week. The intervention also reduced sedentary behavior by 8.2 minutes per day.
The ABSORB clinical trial demonstrated no stent thrombosis and a low rate of major adverse cardiac events (MACE) in patients with coronary artery disease. The bioabsorbable everolimus eluting stent was shown to be safe and effective, with successful deployment and high device success rates.
Scientists at MGH are exploring a potential cure for type 1 diabetes through a Phase I clinical trial. The trial uses the BCG vaccine, which has shown promising results in mouse models of autoimmune diabetes.
A study found that monthly personal contact with a counselor reduced weight regain by 3.3 lbs compared to self-directed programs, while interactive technology-based interventions showed similar results. More than 70% of participants maintained at least 8.8 lbs of weight loss.
A randomized clinical trial found that postoperative chemotherapy does not improve survival in patients with localized gastric cancer. Despite promising results in advanced gastric cancer, the combination of cisplatin, epirubicin, and other chemotherapies did not show significant benefits.
Researchers from the US and China have confirmed the effectiveness of a simple treatment for amblyopia in laboratory and clinical trials. The treatment, which involves training on a visual task, has shown promising results in improving vision and challenging traditional theories about critical periods.
An open-source clinical trial data-management system could save money and empower researchers in resource-poor settings. The system would eliminate the need for expensive database software systems, making high-standard research more accessible.
A new international study has found that increasing the intensity of chemotherapy can reduce mortality rates for children with severe Langerhans cell histiocytosis (LCH) by up to 20 percent. The study, which involved 193 pre-identified patients, demonstrated a statistically significant improvement in prognosis and survival rates.
A multicenter trial found that uterine artery embolization (UAE) is a viable alternative to hysterectomy for women with symptomatic fibroids. After two years, patients who underwent UAE reported health-related quality of life equal to those who had undergone hysterectomy.
A recent study published in The Lancet Neurology found that alteplase treatment can improve clinical outcomes in stroke patients even when administered outside the conventional 3-hour window. The researchers identified patients with an ischaemic penumbra and showed significant benefits in tissue reperfusion and reduced infarct growth.
The Argus II is the second-generation electronic retinal implant designed for treating blindness caused by Retinitis Pigmentosa. It consists of an array of 60 electrodes attached to the retina, conducting information from an external camera to provide rudimentary sight to implanted subjects.
A recent study found that a small proportion of individuals with hypertension eat diets aligned with government guidelines, while many others consume unhealthy patterns. The Dietary Approaches to Stop Hypertension (DASH) trial showed that a balanced diet high in fruits and vegetables can significantly lower blood pressure.
A recent study found a significant association between the combination of aprotinin and angiotensin-converting enzyme (ACE) inhibitors during off-pump cardiac surgery and postoperative renal dysfunction. The study, published in The Lancet, analyzed data from over 9,700 patients undergoing cardiac surgery between 2000 and 2007.